Literature DB >> 7721326

Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages.

V R Naraparaju1, N Yamamoto.   

Abstract

The outer surface of mouse B lymphocytes carries constitutive and inducible beta-galactosidase isozymes. A brief (30 min) treatment of B lymphocytes with lysophosphatidylcholine (lyso-Pc) immediately induced an approximate 3-fold higher beta-galactosidase activity than the constitutive isozyme of untreated B lymphocytes. Thus, the lyso-Pc-inducible isozyme is not a de novo enzyme. Outer surface of mouse T lymphocytes carries constitutive (non-Neu-1) and inducible (Neu-1) sialidase isozymes. The lyso-Pc-inducible beta-galactosidase of B lymphocytes and the Neu-1 sialidase of T lymphocytes were required for conversion of vitamin D3-binding protein (Gc protein) to a potent macrophage activating factor. This enzymatic generation of the macrophage activating factor was mediated via enzyme-associated receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7721326     DOI: 10.1016/0165-2478(94)90214-3

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  15 in total

1.  Decrease in cell surface sialic acid in etoposide-treated Jurkat cells and the role of cell surface sialidase.

Authors:  Y Azuma; A Taniguchi; K Matsumoto
Journal:  Glycoconj J       Date:  2000-05       Impact factor: 2.916

Review 2.  Where catabolism meets signalling: neuraminidase 1 as a modulator of cell receptors.

Authors:  Alexey V Pshezhetsky; Aleksander Hinek
Journal:  Glycoconj J       Date:  2011-09-20       Impact factor: 2.916

3.  A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.

Authors:  N Yamamoto; V R Naraparaju
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

Review 4.  Recent development in mammalian sialidase molecular biology.

Authors:  Eugenio Monti; Augusto Preti; Bruno Venerando; Giuseppe Borsani
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

5.  Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.

Authors:  M Korbelik; V R Naraparaju; N Yamamoto
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

7.  Regulation of phagocytosis in macrophages by neuraminidase 1.

Authors:  Volkan Seyrantepe; Alexandre Iannello; Feng Liang; Evgeny Kanshin; Preethi Jayanth; Suzanne Samarani; Myron R Szewczuk; Ali Ahmad; Alexey V Pshezhetsky
Journal:  J Biol Chem       Date:  2009-11-04       Impact factor: 5.157

8.  Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor.

Authors:  Peng Wang; Ji Zhang; Hong Bian; Ping Wu; Reshma Kuvelkar; Ted T Kung; Yvette Crawley; Robert W Egan; M Motasim Billah
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

9.  Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Authors:  Nobuto Yamamoto; Hirofumi Suyama; Nobuyuki Yamamoto
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

10.  The value of serum alpha-N-acetylgalactosaminidase measurement for the assessment of tumour response to radio- and photodynamic therapy.

Authors:  M Korbelik; V R Naraparaju; N Yamamoto
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.